Skip to main content
Caplight Logo









Marine Biomedical

Marine Biomedical

Private
BroomeHealthcare & Life Scienceshttps://www.marinebiomedical.com.au/

Last Round

Strategic

Jan 16, 2026

Total Funding Raised

$3.15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Marine Biomedical is a biotechnology company that develops and manufactures marine-derived biomaterials, including its flagship bone substitute product PearlBone™, for use in orthopaedic and dental applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Sustainable Materials, Circular Economy

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

bone graft substitutebiomaterialsregenerative medicinebone graftnacrebiocompatible scaffoldsorthopaedic surgerydental surgerymedical device manufacturerbone regenerationbiotechmother of pearlmedtechFDA 510(k)circular economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Marine Biomedical Comparables

Compare Marine Biomedical with similar companies based on industry and business-model similarity.

Marine Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CoreBone
83%
Zoan BioMed
82%
Molecular Matrix, Inc.
78%

Marine Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 16, 2026
Early FundingMay 1, 2025
GrantMay 17, 2022

Key People

Founding team and executive leadership

Rolee Kumar

Chief Executive Officer

Executive Team

Marine Biomedical Investors

Notable investors and investment history

Marine Biomedical investors
InvestorRounds
Government of Western AustraliaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors grew 251% MoM, reaching 842.

  • Jan 16, 2026

    $740K raised, led by Orthocell Ltd

Marine Biomedical Filings

Explore SEC and related filing metadata, where available.

Marine Biomedical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Marine Biomedical's valuation, stock price, and market status.

Is Marine Biomedical a public or private company?

Marine Biomedical is a private company.

What is the current stock price of Marine Biomedical?

Marine Biomedical is a private company with no public stock price. No recent secondary market data is available.

How much is Marine Biomedical worth (valuation)?

Valuation information for Marine Biomedical is not publicly available.

Can I buy Marine Biomedical stock?

Marine Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Marine Biomedical's last funding round?

Funding round information for Marine Biomedical is not publicly available.

Who are the main investors in Marine Biomedical?

Investor information for Marine Biomedical is not publicly disclosed.

Will Marine Biomedical IPO soon?

No public IPO plans have been announced for Marine Biomedical.

How can I track Marine Biomedical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Marine Biomedical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBroome
Employee Range9
Year Founded2021
Last FundingJan 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?